The effect of smoking on the bioavailability of metronidazole in plasma and saliva

Journal of the American Dental Association

Volumn 143, Issue 2, 2012, Pages 149-156

  Montalli, Victor Angelo ^a   De Cassia Bergamaschi, Cristiane ^b   Ramacciato, Juliana Cama ^a   Nolasco, Fabiana Pinchetti ^c   Groppo, Francisco Carlos ^c   De Brito, Rui Barbosa ^a   Haas, Daniel A ^d,e   Motta, Rogerio Heladio Lopes ^a  

^a SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^b UNIVERSITY OF SOROCABA   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d Faculty of Medicine   (Brazil)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bioavailability; Metronidazole; Pharmacokinetic parameters; Plasma; Saliva; Smoking

Indexed keywords

EID: 84857842391     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2012.0125     Document Type: Article

References (57)

1. Leiknes T, Leknes KN, Böe OE, Skavland RJ, Lie T. Topical use of a metronidazole gel in the treatment of sites with symptoms of recurring chronic inflammation. J Periodontal 2007;78(8):1538-1544.
2. Lorentz TC, Cota LO, Cortelli JR, et al. Prospective study of complier individuals under periodontal maintenance therapy: analysis of clinical periodontal parameters, risk predictors and the progression of periodontitis. J Clin Periodontal 2009;36(1):58-67.
3. Giannopoulou C, Cappuyns I, Mombelli A. Effect of smoking on gingival crevicular fluid cytokine profile during experimental gingivitis. J Clin Periodontal 2003;3 (11):996-1002 (Pubitemid 38030409)
4. Boström L, Linder LE, Bergstrfim J. Influence of smoking on the outcome of periodontal surgery: a 5-year follow-up. J Clin Periodontal 1998;25(3):194-201. (Pubitemid 128706521)
5. Breivik T, Gundersen Y, Gjermo P, van Horsten S, Opstad PK. Nicotinic acetylcholine receptor activation mediates nicotine-induced enhancement of experimental periodontitis. J Periodontal Res 2009; 44(3):297-304.
6. Broth well DJ. Should the use of smoking cessation products be promoted by dental offices? An evidence-based report. J Can Dent Assoc 2001;67(3):149-155.
7. Cogo K, Calvi BM, Mariano FS, Franco GC, Goncalves RB, Groppo FC. The effects of nicotine and cotinine on Porphyromonas gingwalis colonisation of epithelial cells. Arch Oral Biol 2009;54 (11):1061-1067.
8. Nogueira-Filho GR, Froes Neto EB, Casati MZ, et al. Nicotine effects on alveolar bone changes induced by occlusal trauma: a histo-metric study in rats. J Periodontal 2004;75(3):348-352. (Pubitemid 38461117)
9. Grossi SG, Goodson JM, Gunsolley JC, et al. Mechanical therapy with adjunctive minocycline microspheres reduces red-complex bacteria in smokers. J Periodontal 2007;78(9): 1741-1750.
10. Hilgers KK, Kinane DF. Smoking, periodontal disease and the role of the dental profession. Int J Dent Hyg 2004;2(2):56-63.
11. Feres M. Antibiotics in the treatment of periodontal diseases: microbiological basis and clinical applications. Ann R Australas Coll Dent Surg 2008;19:37-44.
12. Yek EC, Cintan S, Topcuoglu N, Kulekci G, Issever H, Kantarci A. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J Periodontal 2010;81(7):964-974.
13. Pahkla ER, Koppel T, Saag M, Pahkla R. Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitis. J Clin Periodontal 2005;32(2):163-166. (Pubitemid 40341850)
14. Armitage GC, Robertson PB. The biology, prevention, diagnosis and treatment of periodontal diseases: scientific advances in the United States. JADA 2009; 140(1 suppl):36S-43S.
15. Jessa MJ, Barrett DA, Shaw PN, Spiller RC. Rapid and selective high-performance liquid chromatographic method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice. J Chromatogr B Biomed Appl 1996;677(2):374-379. (Pubitemid 26106262)
16. Pahkla ER, Koppel T, Naaber P, Saag M, Loivukene K. The efficacy of non-surgical and systemic antibiotic treatment on smoking and non-smoking periodontitis patients. Stomatologija 2006;8(4):116-121.
17. Loesche WJ, Schmidt E, Smith BA, Morrison EC, Caffesse R, Hujoel PP. Effects of metronidazole on periodontal treatment needs. J Periodontal 1991;62(4):247-257.
18. Mestnik MJ, Feres M, Figueiredo LC, Duarte PM, Lira EA, Faveri M. Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontal 2010;37(4):353-365.
19. Bergdahl M, Hedstrom L. Metronidazole for the prevention of dry socket after removal of partially impacted mandibular third molar: a randomised controlled trial. Br J Oral Maxillofac Surg 2004;42(6):555-558. (Pubitemid 39497111)
20. Hamilton M, Wolf JL, Rusk J, et al. Effects of smoking on the pharmacokinetics of erlotinib. Clin Cancer Res 2006;12(7 Pt 1): 2166-2171.
21. Zhang S, Liu P, Jiang S, Hong X, Xing H, Xu X. Association of cigarette smoking with steady-state plasma concentration of irbe-sartan in male Chinese with hypertension. Methods Find Exp Clin Pharmacol 2005;27(3):173-178. (Pubitemid 40571211)
22. Garg SK, Ravi Kiran TN. Effect of smoking on phenylbutazone disposition. Int J Clin Pharmacol Ther Toxicol 1982;20(6):289-290. (Pubitemid 12038831)
23. Yue QY, Tomson T, Sawe J. Carbamazepine and cigarette smoking induce differentially the metabolism of codeine in man. Pharmacogenetics 1994;4(4):193-198. (Pubitemid 24269823)
24. Glasson JC, Sawyer WT, Lindley CM, Ginsberg B. Patient-specific factors affecting patient-controlled analgesia dosing. J Pain Palliat Care Pharmacother 2002;16(2):5-21.
25. Teiria H, Rautoma P, Yli-Hankala A. Effect of smoking on dose requirements for vecuronium. Br J Anaesth 1996;76(1):154-155. (Pubitemid 26030233)
26. Carrillo JA, Herraiz AG, Ramos SI, Gervasini G, Vizcaino S, Benftez J. Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine. J Clin Psychopharmacol 2003;23(2):119-127. (Pubitemid 36368788)
27. Wu TH, Chiu CC, Shen WW, et al. Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(8): 1889-1893.
28. Ruiz ME, Conforti P, Fagiolino P, Volonte MG. The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results (published online ahead of print Sept. 27, 2010). Biopharm Drug Dispos 2010;31(8-9):476-485.
29. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002;28:106-176.
30. Kim YG, Kim HJ, Kwon JW, Kim WB, Lee MG. Bioequivalence of clarithromycin tablet formulations assessed in Korean males. Int J Clin Pharmacol Ther 2001;39(8):356-361. (Pubitemid 32707814)
31. Hersh EV. Adverse drug interactions in dental practice: interactions involving antibiotics-part II of a series. J ADA 1999;130(2):236-251
32. de Cássia Bergamaschi C, Motta RH, Franco GC, et al. Effect of sodium diclofenac on the bioavailability of amoxicillin. Int J Antimi-crob Agents 2006;27(5):417-422.
33. Griffiths GS, Smart GJ, Bulman JS, Weiss G, Shrowder J, Newman HN. Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel. J Clin Periodontol 2000;27(12): 910-917.
34. Lopez NJ, Gamonal JA, Martinez B. Repeated metronidazole and amoxicillin treatment of periodontitis: a follow-up study. J Periodontol 2000;71(1):79-89. (Pubitemid 30261710)
35. Pavia M, Nobile CG, Bianco A, Angelillo IF. Meta-analysis of local metronidazole in the treatment of chronic periodontitis. J Periodontol 2004;75(6):830-838. (Pubitemid 39010995)
36. Carvalho LH, D'Avila GB, Leão A, et al. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population, II: microbiological results. J Clin Periodontol 2005;32(4):406-411. (Pubitemid 40569604)
37. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 2007;34(3): 243-253.
38. Moeintaghavi A, Talebi-Ardakani MR, Haerian-Ardakani A, et al. Adjunctive effects of systemic amoxicillin and metronidazole with scaling and root planing: a randomized, placebo controlled clinical trial. J Contemp Dent Pract 2007;8(5):51-59.
39. Haffajee AD, Socransky SS, Patel MR, Song X. Microbial complexes in supragingival plaque. Oral Microbiol Immunol 2008;23(3): 196-205. (Pubitemid 351519449)
40. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002;29(suppl 3):136-159. (Pubitemid 41719448)
41. Sigusch BW, Guntsch A, Pfitzner A, Glockmann E. Enhanced root planing and systemic metronidazole administration improve clinical and microbiological outcomes in a two-step treatment procedure. J Periodontol 2005;76(6):991-997. (Pubitemid 40903843)
42. Kaner D, Bemimoulin JP, Hopfenmuller W, Heber BM, Fried-Mann A. Controlled-delivery cnlorhexidine chip versus amoxicillin/ metronidazole as adjunctive antimicrobial therapy for generalized aggressive periodontitis: a randomized controlled clinical trial. J Clin Periodontol 2007;34(10):880-891.
43. Akincibay H, Orsal SO, Sengiin D, Tozum TF. Systemic administration of doxycycline versus metronidazole plus amoxicillin in the treatment of localized aggressive periodontitis: a clinical and microbiologic study. Quintessence Int 2008;39(2):e33-e39.
44. Machtei EE, Younis MN. The use of 2 antibiotic regimens in aggressive periodontitis: comparison of changes in clinical parameters and gingival crevicular fluid biomarkers. Quintessence Int 2008;39(10):811-819.
45. Van Oosten MA, Notten FJ, Mikx FH. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. J Dent Res 1986;65(12):1420-1423. (Pubitemid 17228570)
46. Daneshmend TK, Homeida M, Kaye CM, Elamin AA, Roberts CJ. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. Gut 1982;23(10):807-813. (Pubitemid 12018506)
47. Mustofa M, Suryawati S, Santoso B. Pharmacokinetics of metronidazole in saliva. Int J Clin Pharmacol Ther Toxicol 1991; 29(12):474-478.
48. Wood BA, Monro AM. Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. Br J Vener Die 1975;51(1):51-53.
49. Jessa MJ, Goddard AF, Barrett DA, Shaw PN, Spiller RC. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice. Br J Clin Pharmacol 1997;44(3):245-253. (Pubitemid 27376251)
50. Ralph ED, Clarke JT, Libke RD, Luthy RP, Kirby WM. Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother 1974;6(6):691-696.
51. Reynolds JEF, Martindale W. The Extra Pharmacopoeia. 30th ed. London: Pharmaceutical Press; 1993:516-521.
52. Baharin B, Palmer RM, Coward P, Wilson RF. Investigation of periodontal destruction patterns in smokers and non-smokers. J Clin Periodontol 2006;33(7):485-490. (Pubitemid 43937632)
53. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm 2007;64(18):1917-1921. (Pubitemid 47462906)
54. Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 1999;36(6):425-438. (Pubitemid 29317490)
55. Benowitz NL, Hukkanen J, Jacob P III. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009; 192:29-60.
56. Van Bambeke F, Tulkens PM. Macrolides: pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 2001;18(suppl 1):17-23.
57. Del Bortolo Ruenis AP, Nobre Franco GC, Baglie S, et al. A PK/PD approach on the effects of clarithromycin against oral and nasal microbiota of healthy volunteers. Int J Clin Pharmacol Ther 2009;47(2):96-103.